CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
about
Clinical development of candidate HIV vaccines: different problems for different vaccinesA Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenGeneration and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.HIV-1 vaccines: challenges and new perspectivesAdvancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates.Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progressionImmune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.Fragmentation of SIV-gag vaccine induces broader T cell responses.Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysPriming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infectionHIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239.Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer.NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.Transcriptional profiling of experimental CD8(+) lymphocyte depletion in rhesus macaques infected with simian immunodeficiency virus SIVmac239Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.Perivascular inflammatory cells in ovine Visna/maedi encephalitis and their possible role in virus infection and lesion progression.ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment.Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
P2860
Q27005008-FF1E5B6A-18C5-438F-92EC-FFF11763078EQ27302081-8702675B-F3F7-44A2-88BE-9105AAE2B51EQ31106756-221E8DD6-5F82-4345-828C-6BF7815CBDC6Q33577972-4485CFE4-A41C-4F09-A175-1CCBA0604E44Q33742529-B350079E-38E0-4B63-A935-0AA9DC44C6E9Q34004816-D8BFD512-048E-4C99-AA62-DE8A6C8643E8Q34292622-8405B885-42DC-4E62-BC13-18B9965CA4FBQ34464743-9E3E76A4-D35E-47E2-90E5-FA27F48EA3CAQ34548297-D78EE9A7-A783-4ABB-89AD-1142D3DD84E9Q34796206-AC1DB3B2-07C6-4FF8-9605-0660551F05B9Q35431516-BA7524CB-C0D2-461D-9AA3-A09D4EEAA0D4Q35592229-710BC854-19BF-4839-ADF2-D19C7E458565Q35677513-DF3D9DFD-4AFE-4F68-A9C5-E72421A1971FQ35883609-95566DC2-A31D-437A-B244-4AB350D37FCAQ36080892-EF1A1C95-E05D-4B72-8FFD-DF2113905F1FQ36140156-B5C1BBFB-72FD-496A-B0F3-C5008CE9C650Q36506883-DA23A237-3EC4-49F6-93C6-E98A30837D3CQ36978926-625901D3-8083-437E-8E75-84450A6010C9Q37610683-1979D863-70A2-4B76-BA68-865B7AC15973Q40111950-30A1309F-BB02-4995-8665-9F8B26A5AC36Q45354308-A4F05109-9BE5-4087-9D7A-D998B43593B2Q47585968-0EFE1F4E-50FF-4AA3-8CBD-FFCEFE87DF44Q52730779-028DDCAF-4DD2-482D-8C30-7B78BA593437
P2860
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@ast
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@en
type
label
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@ast
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@en
prefLabel
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@ast
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@en
P2093
P2860
P1433
P1476
CD8(+)T-cell-mediated control of HIV-1 and SIV infection.
@en
P2093
Georgia D Tomaras
Kevin O Saunders
Stephanie A Freel
P2860
P2888
P304
P356
10.1007/S12026-010-8177-7
P577
2011-04-01T00:00:00Z
P6179
1012240140